2025 HCPCS code J2792

Injection, Rho(D) immune globulin (human), solvent detergent, intravenous

Medical necessity is determined by the patient's Rh-negative status and exposure to Rh-positive blood. Payer policies may vary.

Administered by a healthcare professional in a clinical setting.

IMPORTANT Related codes include J2790 (full dose, 300 mcg, IM), J2791 (100 IU, IM or IV), and CPT code 90384 (full dose, IM). Note that J2792 is specifically for intravenous administration of the solvent detergent treated form.

In simple words: This injection prevents Rh-negative people from developing antibodies against Rh-positive blood, which can happen during pregnancy or a blood transfusion.

This code represents Rho(D) immune globulin, treated with a solvent detergent, for intravenous administration. It is used to prevent Rh hemolytic disease of the newborn (HDN) and isoimmunization in Rh-negative individuals who have received Rh-positive blood transfusions.

Example 1: An Rh-negative pregnant woman receives a dose of Rho(D) immune globulin intravenously at 28 weeks gestation to prevent potential sensitization to Rh-positive fetal blood., An Rh-negative individual receives a mismatched transfusion of Rh-positive blood and is given J2792 to prevent the formation of anti-D antibodies. , An Rh-negative woman experiences a miscarriage or induced abortion and is administered J2792 to prevent Rh sensitization from potential exposure to Rh-positive fetal blood.

Documentation should include the patient's Rh status, reason for administration (e.g., pregnancy, transfusion), dosage given, and route of administration.

  • Specialties:Obstetrics and Gynecology, Hematology, Emergency Medicine
  • Place of Service:Office, Inpatient Hospital, Outpatient Hospital, Ambulatory Surgical Center
** Only Enterprise users with EHR integration can access case-specific answers. Click here to request access.